Premarin was never taken off the market. It remains FDA-approved and available by prescription in the United States today. What actually happened is that a landmark 2002 study linked hormone therapy to serious health risks, triggering a dramatic 32% drop in prescriptions almost overnight. The combination of alarming headlines, shifting medical guidelines, and animal welfare controversies gave many people the impression that Premarin had been pulled, but it wasn’t.
The 2002 Study That Changed Everything
In July 2002, a massive government-funded clinical trial called the Women’s Health Initiative was stopped early because researchers determined that the risks of a popular hormone therapy regimen outweighed its benefits. The trial tested Prempro, a combination of Premarin (conjugated estrogens derived from pregnant mare urine) and a synthetic progesterone. At the time, millions of women took hormone therapy not just for menopause symptoms but because doctors believed it protected the heart.
The results showed the opposite. Women taking the combination therapy had a 29% higher risk of heart disease, a 41% higher risk of stroke, and a 26% higher risk of invasive breast cancer compared to women taking a placebo. These findings upended decades of medical thinking and made international news. The trial’s early termination was itself dramatic, signaling that continuing the study would be unethical given the level of harm detected.
It’s worth noting that the study specifically tested Prempro, the combination product, not Premarin alone. But because Premarin was the estrogen component and the most widely prescribed hormone therapy in the world, the fallout hit it hard. Doctors rapidly scaled back prescriptions for all hormone therapies, and promotional spending by manufacturers dropped in tandem.
Why Prescriptions Plummeted
Before 2002, Premarin was one of the most prescribed drugs in America. Doctors routinely recommended it for hot flashes, bone loss, and supposed cardiovascular protection. After the WHI results, prescribing patterns shifted fast. Hormone therapy prescriptions fell by 32% in the months following the report, and they never returned to their previous levels.
The decline wasn’t because the FDA revoked approval. It happened because doctors and patients lost confidence. Many women stopped their prescriptions on their own after seeing the news coverage. Physicians who had previously prescribed hormone therapy as a long-term preventive measure began limiting it to short-term use for severe menopause symptoms only. The medical consensus flipped from “most postmenopausal women should consider hormone therapy” to “use the lowest dose for the shortest time necessary.”
Black Box Warnings and Their Recent Removal
After the WHI findings, the FDA required black box warnings on hormone therapy products, including Premarin. These are the most serious warnings the FDA can mandate, printed in a bold-bordered box on the label. The warnings flagged increased risks of cardiovascular disease, breast cancer, and probable dementia.
In a notable reversal, the FDA recently initiated the removal of most of these black box warnings. The agency determined that the labeling needed updating to reflect more current and balanced evidence about benefits and risks. Specifically, the FDA is working with manufacturers to remove references to cardiovascular disease, breast cancer, and dementia risks from the boxed warning, though the warning about endometrial cancer for estrogen-alone products remains. The updated guidance also recommends starting hormone therapy within 10 years of menopause onset or before age 60 for the best benefit-to-risk ratio.
The Animal Welfare Factor
Premarin’s name hints at its unusual origin: it stands for Pregnant Mares’ Urine. The drug is manufactured from the urine of pregnant horses kept on specialized ranches, primarily in Canada. This process has drawn sustained criticism from animal welfare groups for decades.
Critics have raised concerns about mares being confined to small stalls for months during pregnancy, wearing rubber urine-collection devices that could cause irritation, and being deliberately dehydrated to concentrate their urine. The manufacturer, along with veterinary inspectors and the American Association of Equine Practitioners, has consistently denied these claims, stating that the horses are well cared for and that ranchers follow a code of practice covering exercise, water intake, nutrition, and veterinary care.
A more difficult issue involves the foals. Hundreds of foals born as a byproduct of the industry are sold at auction each year, with many ending up at feedlots and ultimately slaughtered for European and Asian meat markets. While the industry and veterinary organizations have characterized the PMU ranching system as responsible, the foal surplus has remained a persistent point of controversy. For some women, these ethical concerns became an independent reason to switch away from Premarin, compounding the post-WHI decline.
What Doctors Prescribe Instead
The shift away from Premarin opened the door to alternatives that many physicians now prefer. Plant-derived forms of estradiol, which is chemically identical to the estrogen your body naturally produces, are available in FDA-approved pills, patches, gels, and sprays. Brands like Estrace and Alora deliver estradiol without the mix of horse-derived estrogens found in Premarin. For women who need progesterone alongside estrogen (anyone with an intact uterus), plant-derived options like Prometrium are available.
The appeal of these alternatives is partly practical: a patch or gel delivers estrogen through the skin, bypassing the liver and potentially lowering the risk of blood clots compared to oral formulations. The shift also reflects a broader preference for hormones that match what the human body produces rather than the complex mixture of equine estrogens in Premarin.
Compounding pharmacies also market custom-mixed “bioidentical” hormone preparations, though the Mayo Clinic notes that many FDA-approved products already use natural, plant-derived hormones. The key distinction is that FDA-approved versions undergo standardized testing for safety and consistency, while compounded preparations do not.
Premarin Today
Premarin is still manufactured, still FDA-approved, and still prescribed. It is available in oral tablet and injectable forms. Some women and their doctors choose it deliberately, particularly those who have used it successfully for years or who prefer its specific formulation. But it occupies a far smaller corner of the market than it once did. The combination of health scares, evolving medical guidelines, newer alternatives, and animal welfare concerns collectively shrank its dominance without ever formally removing it from pharmacy shelves.